|
|
Previous Article | Table of Contents | Next Article 
Blood, 15 March 2001, Vol. 97, No. 6, pp. 1787-1795
IMMUNOBIOLOGY
Down-regulation of CD8+ T-cell expansions in patients
with human immunodeficiency virus infection receiving highly active
combination therapy
Guy Gorochov,
Avidan U. Neumann,
Christophe Parizot,
Taisheng Li,
Christine Katlama, and
Patrice Debré
From the Laboratoire d'Immunologie Cellulaire, Hopital
Pitié-Salpétrière; the Department of Infectious
Diseases and Tropical Medicine, Hopital
Pitié-Salpétrière, Paris, France; and the Faculty of
Life Sciences, Bar-Ilan University, Ramat-Gan, Israel.
Analysis of T-cell receptor (TCR) repertoire usage made by
peripheral T lymphocytes during the chronic phase of HIV-1 infection has revealed the presence of clonal expansions of CD8 T cells that are
also shown to be largely HIV-specific. Yet, it remains unclear whether
the global repertoire perturbation observed during the chronic phase of
the infection is also HIV-related and reversible in the long term with
the application of highly active antiretroviral therapy. Furthermore,
the diversity and the stability of repertoire usage after a relapse of
viral replication were never examined. Eight patients were observed
longitudinally up to 31 months under triple-association therapy. When
viral replication was steadily suppressed, CD8 repertoires were
significantly stabilized. Conversely, in situations of incomplete or
only transient viral suppression, persistence or rebound in repertoire
perturbation was observed. Finally, a T-cell response remarkably
different from baseline, as reflected by a repertoire switch, was
generated after the discontinuation of highly active therapy. In
conclusion, a sustained control of HIV replication correlated with
profound modifications of the CD8 repertoire usage. These data also
suggested that autovaccination by the withdrawal of antiviral drugs
would result in the selection and expansion of T-cell clones that were
not necessarily dominant before the onset of treatment.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Yang, T. Dong, E. Turnbull, S. Ranasinghe, B. Ondondo, N. Goonetilleke, N. Winstone, K. di Gleria, P. Bowness, C. Conlon, et al.
Broad TCR Usage in Functional HIV-1-Specific CD8+ T Cell Expansions Driven by Vaccination during Highly Active Antiretroviral Therapy
J. Immunol.,
July 1, 2007;
179(1):
597 - 606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Rizzo, G. Brancaccio, D. De Vito, and G. Rizzo
Efficacy of autovaccination therapy on post-coronary artery bypass grafting methicillin-resistant Staphylococcus aureus mediastinitis
Interactive CardioVascular and Thoracic Surgery,
April 1, 2007;
6(2):
228 - 229.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Meyer-Olson, K. W. Brady, M. T. Bartman, K. M. O'Sullivan, B. C. Simons, J. A. Conrad, C. B. Duncan, S. Lorey, A. Siddique, R. Draenert, et al.
Fluctuations of functionally distinct CD8+ T-cell clonotypes demonstrate flexibility of the HIV-specific TCR repertoire
Blood,
March 15, 2006;
107(6):
2373 - 2383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Miyara, Z. Amoura, C. Parizot, C. Badoual, K. Dorgham, S. Trad, M. Kambouchner, D. Valeyre, C. Chapelon-Abric, P. Debre, et al.
The immune paradox of sarcoidosis and regulatory T cells
J. Exp. Med.,
February 21, 2006;
203(2):
359 - 370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. N. Posnett, M. E. Engelhorn, and A. N. Houghton
Antiviral T cell responses: phalanx or multipronged attack?
J. Exp. Med.,
June 20, 2005;
201(12):
1881 - 1884.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E Hodges, M T Krishna, C Pickard, and J L Smith
Diagnostic role of tests for T cell receptor (TCR) genes
J. Clin. Pathol.,
January 1, 2003;
56(1):
1 - 11.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Benveniste, P. Cherin, T. Maisonobe, R. Merat, O. Chosidow, L. Mouthon, L. Guillevin, A. Flahault, M.-C. Burland, D. Klatzmann, et al.
Severe Perturbations of the Blood T Cell Repertoire in Polymyositis, But Not Dermatomyositis Patients
J. Immunol.,
September 15, 2001;
167(6):
3521 - 3529.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|